IP 株価分析 — INTER PHARMA PUBLIC COMPANY LIMITED (Healthcare >> Biotechnology)
IP に関するよくある質問
IPのPER(株価収益率)は?
INTER PHARMA PUBLIC COMPANY LIMITED(IP)は現在PER 24.11倍で取引されています。
IPのROE(自己資本利益率)は?
INTER PHARMA PUBLIC COMPANY LIMITEDのROEは6.35%です。
IPの配当利回りは?
INTER PHARMA PUBLIC COMPANY LIMITEDの配当利回りは1.36%です。
IPの品質スコア(Quality Score)は?
当社のAIはIPの総合財務品質を100点中69点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
IPは今が買い時ですか?
当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
IPはどのセクターに属しますか?
INTER PHARMA PUBLIC COMPANY LIMITEDはHealthcare >> Biotechnologyセクターに分類されます(MAI市場)
IP AI Analysis Summary
Our AI summary for IP: INTER PHARMA PUBLIC COMPANY LIMITED (MAI), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 24.11, ROE of 6.35%, a dividend yield of 1.36%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
THB 5.30
Price
-0.05
(-0.93%)
Day Change
|
|
|---|
IP, ファンダメンタルスコアはok ( ファンダメンタル = 69) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEが低い
平均ROEが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.05 From 30 days period |
| Watch Rate | 0.12 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
512
|
| Magic Formula Rank by ROE |
512
|
| Magic Formula Rank by ROIC |
517
|
| Price | 5.30 |
| PBV / Sector |
1.37 / 1.37
GOOD
|
| Earning Per Share | 0.22 |
| PE / Sector |
24.11 / 24.11
|
| PEG or PE/Growth / Sector |
0.65 / 0.65
|
| Average 1M Daily Value |
2.72 M
GREAT
|
| Average 1W Daily Value |
2.47 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
62% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-08-01 05:27:13 |
| Symbol | IP |
| Name | INTER PHARMA PUBLIC COMPANY LIMITED |
| Sector | Healthcare >> Biotechnology |
| Market | MAI |
| Listed Shares | 605.34 M |
| Par Value | 1.00 |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.Baht) / Sector Average | 3,208.33 / 3,208.33 |
| ニュース |
| Estimation Consensus | See at SetTrade.com |
| Full details | See at SET.or.th |
| Chart | See in Chart feature |
| News | See at RYT9.com |
Address: No. 140/9 ITF Tower, Bangkok, Thailand, 10500
Phone: 66 2 634 0225
Website: https://www.interpharma.co.th
Sector: Healthcare >> Biotechnology
Description: Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equipment and medicines, etc. It also provides pet healthcare and livestock products, such as medical supplies, nutrition therapy, vaccine, supplementary food, probiotic and prebiotic products, animal health food products, animal food, general formula animal food, nutraceuticals and medicine companion products, ear and teeth cleaners, pee pads, shampoos, and medical equipment related to pet and livestock care product, etc. In addition, the company provides care and treatment for patients with general and specialized diseases, such as cardiovascular disease, bone and joint disease, neuropathy, medical diseases, surgical diseases, kidney disease, obstetrics and gynecology, ear, eye, nose, throat diseases, blood diseases, pediatric clinics, etc. It serves retail customers through distributors. The company was incorporated in 2006 and is headquartered in Bangkok, Thailand.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google